Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- John Connett, PhD
University of Minnesota
Principal Investigator - Stephen Lazarus, MD
University of California, San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Birmingham, Alabama Va Medical
Birmingham, Alabama, United States
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of California, San Francisco-Fresno
Fresno, California, United States
- la Biomed at Harbor-Ucla Medical Center
Los Angeles, California, United States
- University of California at San Francisco
San Francisco, California, United States
- National Jewish Medical & Research Center
Denver, Colorado, United States
- North Florida/south Georgia Veterans Health System
Gainesville, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- Louisiana State University
New Orleans, Louisiana, United States
- University of Maryland Baltimore
Baltimore, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Va Ann Arbor Healthcare System
Ann Arbor, Michigan, United States
- Healthpartners Research Foundation
Minneapolis, Minnesota, United States
- Veteran'S Administration Medical Center
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Newyork-Presbyterian Brooklyn Methodist Hospital
Brooklyn, New York, United States
- New York Presbyterian/queens
Flushing, New York, United States
- Cornell University
Ithaca, New York, United States
- Columbia University
New York, New York, United States
- Cincinnati Va Medical Center
Cincinnati, Ohio, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Temple University Lung Center
Philadelphia, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- University of Utah Health Sciences Center
Salt Lake City, Utah, United States
- the University of Vermont
Burlington, Vermont, United States
- University of Washington School of Medicine
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 May 2016
- Primary completion
- 1 Sept 2019
- Completion
- 1 Dec 2019
- Last update posted
- 25 Jan 2021
- Registered enrollment
- 532
- Registry id
- NCT02587351
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.